The Rewarding Career Path From a Study Technician to a Clinical Veterinarian

As a biology major, Tai had always planned on being a medical doctor, but when she reached her senior year in college she decided to explore other professions.

"My family had always told me, 'you will be a doctor,' and I didn't think twice about it. But when I was finishing my undergraduate degree, I realized I wanted to figure out another way to make a difference with my career."

After graduating, Tai explored positions in a variety of areas, including a volunteer position with the local humane society. At the shelter, she met another volunteer who was in a program to become a veterinary technician, and who encouraged her to learn more about the line of work.

“I enjoy working with animals, and a career in the veterinary field seemed like something that I could be excited about getting up for every morning,” Tai shared.

Starting a career with Covance, the drug development company of LabCorp

As she was completing her veterinary technology program, Tai needed to decide where, such as an animal hospital, research laboratory, animal shelter or private veterinary center, she wanted to work in the industry. Her program invited different guest speakers across the veterinary technology community to share their roles with the students.

"Hearing the guest speaker from a local research laboratory made me interested in learning more about the research side of the vet tech role. It seemed like a natural fit to work with animals and apply my scientific background from my undergraduate studies," said Tai.

"When I became a licensed vet tech, a position for a study technician at Covance was available. I applied and was hired. Even though I had a 90-minute commute each way, I literally loved every single moment of the job."

Recognizing the value of animal welfare

Although Tai had been inspired by the research technician who visited her vet tech program, she still wasn’t entirely sure what she would be doing as a study technician.

"I think the reason a lot of people don't go into laboratory animal medicine is because they are not sure what it is about. I think people will find it's much different than they expected," said Tai. "When I started, I only had a vague idea about animal research and what it meant, but Covance provided me with a lot of on-the-job training."

Tai also learned how study techs can help ensure that animal welfare remains a top priority.

"One day while we were running a study, a fellow study tech noticed an issue with a mouse. We called the veterinarian and he was there in less than five minutes to evaluate the mouse and make sure it got the care it needed. I saw first-hand how the animals were treated humanely and with respect, and valued the importance of my role as the voice for these animals."

Growing her career and recognizing her impact on healthcare

Inspired by her work as a study tech, Tai decided to continue her education in the field. She left Covance and enrolled in a veterinary medicine program, earning her degree as a Doctor of Veterinary Medicine (DVM). During her studies, she and her husband adopted two red-footed tortoises after being a volunteer coordinator for the tortoises on campus. "We fell in love with the tortoises," she laughed. "They have unique personalities, believe it or not."

After completing both an internship and a residency program in laboratory animal medicine, she rejoined Covance, this time as a Clinical Veterinarian.

"I came back seven years later, and saw that some of the same people are still at Covance, including the veterinarian that had made such a positive impression on me," she said. "I was so excited to be working with some of the same staff."

Beyond working with familiar faces, Tai is motivated by her role in improving laboratory animal medicine.

"Good research comes from happy, healthy animals. I take pride in advocating for our animals and making a positive impact in their lives," explained Tai. "Whether I am helping refine procedures to improve animal welfare, ensuring animals have the right enrichment in their environments, or simply changing cages, I enjoy the process of caring for our animals. Ultimately, I see how the care we provide for our animals results in valuable data that helps ground-breaking drugs come to life for both humans and animals alike."

Learn more about our study tech opportunities here.

在炎症性肠病临床研究中最大限度地减少安慰剂的作用

With 93 Crohn’s Disease (CD) and 168 Ulcerative Colitis (UC) Phase I-III industry-sponsored studies planned and open to enrollment, there is a significant focus on research into new therapies for inflammatory bowel disease (IBD)1.

Remission is the main aim of IBD therapy, but IBD studies often face challenges with minimizing the placebo effect2,3,4. Placebo effect can be categorized into placebo response/benefit (patients demonstrating an improvement) or placebo remission (patients achieving remission). Factors believed to impact the level of placebo effect can be contradictory depending upon whether a study’s focus is upon placebo response/benefit or placebo remission5.

继续阅读

如何续展植物保护产品——美国法规

今年预计将有重要的专利过期,同时农用化学品公司之间的并购活动也将改变竞争格局。在此背景下,有关成熟活性物质的历史、知识和洞见可能“丢失”,而此类变化可能给植物保护产品(PPP)重新授权带来风险。敬请详细了解。

继续阅读

英国脱欧:利用相互承认的协议降低商业药品发布测试的潜在风险

英国脱欧1的最后期限再次推后——现在延期至2020年1月31日,同时,考虑到12月12日大选的结果,达成退出协议可能性似乎更大。尽管如此,药物制造商和合同测试实验室仍应积极主动地了解与商业药品发布测试及英国脱欧有关的潜在监管考虑。

本文简要介绍了欧盟-美国相互承认的协议(MRA),并讨论了在英国脱欧取得进展时,实施可行的替代测试以支持欧盟、英国和美国药品发布的考虑因素。

继续阅读

ECHA决定书 - 有何期望

REACH的最后期限为2018年5月,届时对欧盟/欧洲经济区境内所销售化学产品的安全性的主动信息收集期将结束。这促成建立了有关广泛物质的安全性信息的大型数据库,并预示着科学和监管思维的发展将进入一个令人振奋的新阶段。因此,随着数据出炉,决定书也开始发布。

继续阅读

Oren Cohen(医学博士)回顾了自己在1980年代艾滋病毒流行期间担任感染疾病医师的经历

12月1日(周日)是世界艾滋病日,旨在提高人们对由HIV感染传播引起的AIDS大流行的认识,并纪念那些死于该疾病的人们。世界艾滋病日自1988年起确立。

科文斯首席医学官Oren Cohen(医学博士)在艾滋病流行初期曾是纽约市的一名传染病医生,并分享了这段回忆:

继续阅读

作物残留分析的田间试验 - 成功的7个秘诀是什么?

Residues of plant protection products (PPPs) are inevitably present in or on food, even when they are applied in line with good agricultural practice. The upper limit of residue permitted on food or feed is the 'maximum residue level' (MRL), which, in Europe, is legislated by the European Commission based on scientific advice from the (EFSA).

MRLs are measured via crop residue field trials, which replicate the real-life agricultural conditions under which a PPP would be used. 这听起来很简单,但通常会使用哪些研究?成功的秘诀又是什么?

继续阅读

通过真实证据(RWE)研究填补知识缺口:及早开始的重要性

在随机临床试验中成功证明产品安全性与功效的意义巨大,但这并不总是意味着产品能够获得市场准入,并在发布后得到接受。由于临床试验局限于受控的患者子集,在临床试验中记录的观察结果可能与临床应用中的实际情况有所出入。在这种情况下,真实证据(RWE)可帮助制药公司为研发规划提供信息,并从不同利益相关方的角度证明产品的比较功效、安全性和价值,包括监管方、支付方、开处方者与患者。

本文讨论了RWE的作用、利益相关方的不同信息需求以及可满足其不断变化的要求的潜在解决方案。

继续阅读